Name: Latest research reports of Gland Pharma Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Gland Pharma Ltd.
Rating: 5
Author: Motilal Oswal

Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

2826.8000 -23.60 (-0.83%)

NSE Oct 23, 2026 15:31 PM

79.64% Gain from 52W Low

Volume: 423.1K

Gland Pharma Ltd.

06 Aug 2025

2826.80

-0.83%

Strong margin gain boosts PAT by 50% YoY

Buy: Gland Pharma Ltd.

Target

Motilal Oswal

Gland Pharma (GLAND) posted revenue in line with our estimate in 1QFY26. However, EBITDA/PAT exceeded our estimates (13%/16% beat).

Gland Pharma Ltd. is trading above its 200 day SMA of 2241.9